Form 4: Oragenics Director Fred Telling Sells 3,597 Shares

Director Fred Telling sold 3,597 shares of Oragenics Inc. at a price of $0.36 per share on December 6, 2024.

Summary

• Fred Telling, a director at Oragenics Inc., sold 3,597 shares of common stock on December 6, 2024.
• The sale price was $0.36 per share.
• Following the transaction, Mr. Telling directly owns 34,748 shares of Oragenics Inc.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by a director, with no inherent positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The sale by Fred Telling is a relatively small transaction compared to the overall market capitalization of Oragenics Inc.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on the company's operations or other stakeholders.

Key Dates

Keywords

Oragenics, Director, Fred Telling, Stock Sale, Share Transaction, Insider Trading, OGEN